Kjer's optic neuropathy
(Redirected from Doa)
Kjer's optic neuropathy is a rare, inherited disorder that primarily affects the eyes, leading to vision loss. This condition is characterized by the onset of visual impairment in early childhood, which is typically severe by the second decade of life. Most affected individuals are legally blind by mid-adulthood. Despite severe vision loss, other eye-related symptoms are typically mild and most people with Kjer's optic neuropathy do not experience pain or discomfort in their eyes.
Signs and Symptoms[edit | edit source]
The primary symptom of Kjer's optic neuropathy is vision loss, which begins in early childhood. This vision loss is progressive, meaning it worsens over time. By the second decade of life, most individuals with this condition have severe vision loss. Despite this, other symptoms related to the eyes are typically mild. Most individuals do not experience pain or discomfort in their eyes.
Causes[edit | edit source]
Kjer's optic neuropathy is caused by mutations in the OPA1 gene. This gene provides instructions for making a protein that is found in cells throughout the body, including cells in the eye. The OPA1 protein is involved in maintaining the structure and function of mitochondria, which are the energy-producing centers within cells. Mutations in the OPA1 gene disrupt the function of the OPA1 protein, leading to the vision loss seen in Kjer's optic neuropathy.
Diagnosis[edit | edit source]
The diagnosis of Kjer's optic neuropathy is based on the presence of characteristic clinical features, including early-onset, progressive vision loss. Genetic testing can confirm the diagnosis by identifying a mutation in the OPA1 gene.
Treatment[edit | edit source]
There is currently no cure for Kjer's optic neuropathy. Treatment is focused on managing symptoms and improving quality of life. This may include the use of low-vision aids, such as magnifying glasses and large-print materials.
Prognosis[edit | edit source]
The prognosis for individuals with Kjer's optic neuropathy varies. Most individuals experience severe vision loss by the second decade of life and are legally blind by mid-adulthood. However, other eye-related symptoms are typically mild and most individuals do not experience pain or discomfort in their eyes.
See Also[edit | edit source]
| Kjer's optic neuropathy Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
